for the Period Ended 31 July 2024
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 July 2024
Principal activities of the company
Directors
The directors shown below have held office during the whole of the period from
1 August 2023
to
31 July 2024
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
2024 | 2023 | |
---|---|---|
|
£ |
£ |
Turnover: |
|
|
Cost of sales: |
(
|
(
|
Gross profit(or loss): |
|
|
Administrative expenses: |
(
|
(
|
Operating profit(or loss): |
( |
|
Interest receivable and similar income: |
|
|
Interest payable and similar charges: |
(
|
|
Profit(or loss) before tax: |
|
|
Tax: |
(
|
(
|
Profit(or loss) for the financial year: |
|
|
As at
Notes | 2024 | 2023 | |
---|---|---|---|
|
£ |
£ |
|
Fixed assets | |||
Tangible assets: | 3 |
|
|
Total fixed assets: |
|
|
|
Current assets | |||
Debtors: | 4 |
|
|
Cash at bank and in hand: |
|
|
|
Total current assets: |
|
|
|
Creditors: amounts falling due within one year: | 5 |
(
|
(
|
Net current assets (liabilities): |
|
|
|
Total assets less current liabilities: |
|
|
|
Total net assets (liabilities): |
|
|
|
Members' funds | |||
Profit and loss account: |
|
|
|
Total members' funds: |
|
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 July 2024
Basis of measurement and preparation
Turnover policy
Tangible fixed assets depreciation policy
Other accounting policies
for the Period Ended 31 July 2024
2024 | 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 31 July 2024
Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
---|---|---|---|---|---|---|
Cost | £ | £ | £ | £ | £ | £ |
At 1 August 2023 |
|
|
||||
Additions | ||||||
Disposals |
(
|
(
|
||||
Revaluations | ||||||
Transfers | ||||||
At 31 July 2024 |
|
|
||||
Depreciation | ||||||
At 1 August 2023 |
|
|
||||
Charge for year |
|
|
||||
On disposals |
(
|
(
|
||||
Other adjustments | ||||||
At 31 July 2024 |
|
|
||||
Net book value | ||||||
At 31 July 2024 |
|
|
||||
At 31 July 2023 |
|
|
for the Period Ended 31 July 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Trade debtors |
|
|
Total |
|
|
for the Period Ended 31 July 2024
2024 | 2023 | |
---|---|---|
£ | £ | |
Trade creditors |
|
|
Taxation and social security |
|
|
Other creditors |
|
|
Total |
|
|
for the Period Ended 31 July 2024
During financial year 2023/2024 The Company submitted evidence to a number of consultations, enquiries and calls for evidence. This included responses and contributions to: Just Fair’s submission to the UN Committee on Economic, Social & Cultural Rights NHS England’s Stakeholder and Public Consultations on a new referral pathway for children & young people’s gender incongruence service The Electoral Commission’s Report on the May 2023 local elections in England NHS’s England Interim Clinical Policy Consultation: Puberty suppressing hormones for children and adolescents who have gender incongruence/dysphoria The General Optical Council’s Consultation on removing reference to a registrant’s gender on the public register A joint response (with Trans Media Watch) to the Communications and Digital Committee’s inquiry, The future of news: impartiality, trust and technology. The DfE consultation on Guidance for Schools and Colleges on Gender Questioning Children Healthcare Improvement Scotland’s consultation on Gender identity healthcare services standards The Consultation on changes to the NHS Constitution Our work advocating for trans people during this financial year has also included: Attending regular meetings with NHS Specialised Commissioning. Meeting with MPs and Ministers to ensure they understand trans people’s needs. Taking the Secretary of State for Health and Social Care to judicial review in a dispute over legality of the emergency ban on puberty blockers. We have continued to use our social media channels and website to provide insight into the lived experiences of trans people from a wide range of backgrounds, as well as providing information for community members and our wider society. This financial year, we also migrated our website and reviewed its user experience. The Company published ‘What Do I Need To Know About Surgery?’ This resource for trans people who are in the process of accessing transition-related surgery was funded by the TRANSforming Futures Partnership. They also funded a programme of 4 webinars for healthcare professionals on various aspects of trans people’s healthcare needs. There was good uptake of these webinars and we received positive feedback. Thanks to funding from LGBT Consortium’s Equity Fund, we conducted research into trans people’s healthcare experiences. This research was used to produce our ‘Trans Inclusive Care?’ report, which then informed the development of a resource for hospital staff: ‘Trans Inclusive Hospital Care’. The Company delivered training on trans-inclusion to a number of NHS trusts and ICBs, as well as to other organisations. The Company are active members of the wider sector in which we work and in particularly is regularly engaged with LGBT Consortium, the National LGBT Partnership, National Voices, and the CQC’s Public Engagement Network. We have supported a number of researchers whose research focuses on trans people’s needs – in some instances this has involved being members of the Community Advisory Board or being interviewed for their research, in others we have simply posted their recruitment materials on our social media channels. The Company continues to convene the Trans Health Forum on a quarterly basis, bringing third sector organisations, activists and academics together to network and promote collaboration. Following the announcement of the review into NHS England’s adult gender services, The Company convened the Trans Healthcare Coalition, which is a group of organisations and individuals who are working together to advocate for trans people’s needs within this process. We have continued to seek to engage with the press, although a number of challenges still remain here. Over the course of the financial year, members of the team have made speaking appearances at a range of conferences and events, including a number of LGBTQ+ specific trade union conferences.
The Company holds regular meetings with volunteers throughout the year to discuss work programmes, particularly around healthcare and social media. Work plans are developed in conjunction with these volunteer groups. During the development stages of the Company’s ‘What Do I Need To Know About Surgery?’ resource, the Company sought input from the wider trans community. The survey asked people what they wanted to know about transition related surgery, what they wished they’d known, and for top tips for another person pursuing transition-related surgery. The Company also held a focus group to gather additional feedback. The Company consult with medical professionals prior to publishing any resources that may have clinical implications, and we consulted with some individual clinicians on our What Do I Need To Know About Surgery? resource as well as on our Trans Inclusive Hospital Care resource. The Company has an established Legal Advisory Board and consult with lawyers before publishing any resources about rights and protections. The Legal Advisory Board also support strategic decision making in relation to litigation. In June 2024 the Company published ‘Trans Inclusive Care?’ a report on trans people’s experiences when seeking healthcare.
Helen Belcher - £1,852 Chay Brown - £30,510 jane fae - £400 Maryam Din - £415 Keyne Walker - £0
No transfer of assets other than for full consideration
This report was approved by the board of directors on
18 April 2025
And signed on behalf of the board by:
Name: Chay Brown
Status: Director